LATEST NEWS
- In the News
With the global supply of Covid-19 vaccine still woefully inadequate, vaccine makers are scouring the pharmaceutical landscape for partners to ramp up manufacturing
- Behind the Science
New A.P. Giannini Foundation Fellowship opens the door to an in-depth look at SARS-CoV-2 infections
- Research News
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
- In the News
Study compares four vaccines and natural immunity
- Research News
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
- Research News
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
- In the News
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
- Immune Matters
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
- Immune Matters
San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
- Immune Matters
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
- Behind the Science
San Diego artist Patricia Pauchnick on how she assembled her illustration for the Immune Matters magazine article "How Pandemics End"
